Navigation Links
Butamax™ and Fagen Announce Collaboration to Retrofit Ethanol Plants for Biobutanol Production
Date:4/19/2012

WILMINGTON, Del., April 19, 2012 /PRNewswire/ -- Butamax™ Advanced Biofuels, LLC, a joint venture between BP and DuPont, announced today that it has entered into collaboration with Fagen, Inc. for the introduction of commercial biobutanol production using Butamax™ technology. Fagen is the world's most experienced biofuels engineering, procurement and construction contractor, having built more ethanol capacity than any other company.  They are the largest, most respected green energy design builder in the U.S. and have constructed over 85 ethanol plants totaling approximately 6 billion gallons of annual production. Fagen's extensive experience with ethanol production facilities and Butamax's pioneering biobutanol technology provides strong synergy for the rapid scale-up of biobutanol production.

(Logo: http://photos.prnewswire.com/prnh/20120419/DE90615LOGO )

(Logo:  http://photos.prnewswire.com/prnh/20120209/MM50763LOGO )

"We are delighted to partner with Fagen on our path to commercialize biobutanol," said Paul Beckwith, Butamax CEO. "Fagen is simply the world leader when it comes to project execution in the biofuels industry, with leading standards for safety and quality. Our shared commitment to renewable energy makes Fagen a natural partner for Butamax and our shareholders."

"Butamax offers an exciting opportunity for ethanol facilities to leverage their existing assets to produce the next generation biofuel," said Aaron Fagen, CEO Fagen, Inc., "We look forward to working with Butamax in the deployment of their commercial strategy and their first retrofit project starting in 2013." 

Butamax was the first company to identify the opportunities and technology for cost-effective production of isobutanol through advanced biotechnology.  The company announced last December the formation of the Early Adopters Group (EAG), a consortium of world-class biofuel production companies interested in becoming early adopters of Butamax™ biobutanol technology. In addition, piloting work continues at the Butamax Technology Demonstration facility as the company prepares for market entry with commercial production in 2014.

About Butamax

Butamax™ Advanced Biofuels, LLC was formed to develop and commercialize biobutanol as a next generation renewable biofuel for the transport market. The company benefits from the synergy of DuPont's proven industrial biotechnology experience and BP's global fuels market knowledge. Butamax's proprietary technology offers a cost-advantaged manufacturing process for isobutanol with value from field to pump. For more information about Butamax, visit www.butamax.com.

About Fagen

Fagen, Inc. is a full service industrial contractor and the largest green energy design-builder in the U.S. Utilizing a database of over 25,000 highly skilled craftworkers, Fagen, Inc. has constructed 60% of the ethanol production capacity in the United States, as well as multiple wind, solar, and power projects. The unmatched standard for safety, quality, and service has led Fagen, Inc. to be consistently listed in the Top 400 Contractors by Engineering News Record. For more information about Fagen, visit www.fageninc.com.

Butamax™ is a trademark of Butamax™ Advanced Biofuels, LLC.

Butamax Contact: Pam Schools

910-777-7119

pamela.schools@butamax.com


Fagen, Inc. Contact: Becky Dahl

320-564-5263

bdahl@fageninc.com


'/>"/>
SOURCE Butamax Advanced Biofuels, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Butamax™ Responds to Gevo Patent Infringement Lawsuit
2. Goodwin Biotechnology and RAFAGEN Announce a Collaboration
3. Medivir Announces TMC435 in an Expanded Clinical Collaboration
4. Inspiration Biopharmaceuticals Announces Filing of Biologics License Application (BLA) for IB1001, a Recombinant Factor IX Product for People with Hemophilia B
5. CardioInsight Announces Appointment of Jim Bullock as Chairman of the Board of Directors
6. WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment
7. Custom Spine Announces 510K Clearance for Securis Cannulated Screw System
8. UBM Canon, the Global MedTech Authority, and the Medical Design Excellence Awards Announce Dean Kamen as the Presenter of the 2012 Lifetime Achievement Award
9. BioRestorative Therapies Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure
10. Islet Sciences Announces Receipt of $2.1 Million in Grant Support of Technology
11. ADVENTRX Announces Establishment of Regulatory Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused on drug delivery, ... Health (NIMH) for the further advancement of the company’s 3-month olanzapine product ( DLP-119 ... to deliver therapeutic levels of olanzapine for a period of 3 months., “We are ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, a ... a new category of therapeutics, announced today the completion ... in peripheral artery disease. The trial will evaluate the ... therapeutic, in the reduction of restenosis following angioplasty. ... development milestone for SB-030," said Nathan Bachtell , ...
(Date:2/24/2017)... 23, 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ... biopharmaceutical company in China, today announced its financial results for ... Fourth Quarter 2016 Financial Highlights ... 21.7% in RMB terms, or increased by 13.6% in USD ... quarter of 2015. Gross profit increased by ...
(Date:2/23/2017)... 23, 2017 ... per share data, unaudited)Three Months Ended December 31,Twelve Months ... $         ...   89026%Aldurazyme Net Product Revenue ... Net Product Revenue  756025%297303(2)%Vimizim Net ...
Breaking Biology Technology:
(Date:2/8/2017)... -- Report Highlights The global biosurgery market ... in 2016 at a compound annual growth rate (CAGR) ... - An overview of the global market for biosurgery. ... 2015 and 2016, and projections of compound annual growth ... on the basis of product type, source, application, and ...
(Date:2/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... at the LEERINK Partners 6th Annual Global Healthcare Conference ... February 15, 2017 at 10 a.m. Eastern Time. ... be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast will ... Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:2/6/2017)... Feb. 6, 2017 According to Acuity ... driving border authorities to continue to embrace biometric ... are 2143 Automated Border Control (ABC) eGates and ... at more than 163 ports of entry across ... 2016 achieving a combined CAGR of 37%. APC ...
Breaking Biology News(10 mins):